Fieldpoint Private Securities’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
$130K Buy
3,040
+1,290
+74% +$61.4K 0.04% 316
2022
Q1
$94K Sell
1,750
-100
-5% -$5.82K 0.02% 442
2021
Q4
$133K Buy
1,850
+270
+17% +$16.9K 0.03% 387
2021
Q3
$90K Sell
1,580
-460
-23% -$28K 0.02% 435
2021
Q2
$126K Buy
2,040
+260
+15% +$16.4K 0.03% 374
2021
Q1
$106K Sell
1,780
-50
-3% -$2.72K 0.02% 392
2020
Q4
$86K Buy
+1,830
New +$77K 0.02% 415
2020
Q1
Sell
-2,110
Closed -$62K 436
2019
Q4
$62K Sell
2,110
-50
-2% -$1.33K 0.02% 391
2019
Q3
$50K Sell
2,160
-380
-15% -$7.98K 0.02% 390
2019
Q2
$48K Buy
+2,540
New +$48.2K 0.02% 433

Other funds holding LRCX

Fieldpoint Private Securities's LRCX Position: Q2 2022 in Review

Fieldpoint Private Securities increased its Lam Research (LRCX) stake by 74% in Q2 2022, buying an estimated $61.4K and bringing the position to 3,040 shares worth $130K. The position accounts for 0.04% of the portfolio, ranked #316.

Fieldpoint Private Securities first reported a position in LRCX in Q2 2019 and has held it in 10 quarters since. The position peaked at $133K in Q4 2021. 1,307 funds tracked by Wall St. Rank hold LRCX as of Q2 2022.

  • Fieldpoint Private Securities held 3,040 shares of Lam Research worth $130K as of Q2 2022.
  • Fieldpoint Private Securities bought 1,290 Lam Research shares in Q2 2022, an estimated $61.4K.
  • Lam Research made up 0.04% of Fieldpoint Private Securities's portfolio in Q2 2022, its #316 holding.
  • Fieldpoint Private Securities first reported a position in Lam Research in Q2 2019 and has held it in 10 quarters since.
  • Fieldpoint Private Securities's Lam Research position peaked at $133K in Q4 2021.
  • 1,307 funds tracked by Wall St. Rank held Lam Research as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.